4//SEC Filing
WOOD LAUREN 4
Accession 0001140361-20-027869
CIK 0001472091other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:17 PM ET
Size
5.6 KB
Accession
0001140361-20-027869
Insider Transaction Report
Form 4
WOOD LAUREN
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-12-08+210,500→ 210,500 totalExercise: $2.43Exp: 2030-12-08→ Common Stock (210,500 underlying)
Footnotes (1)
- [F1]The option was granted on December 8, 2020, subject to stockholder approval of the Issuer's Second Amended and Restated 2014 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, one-quarter of the shares subject to the option shall vest on December 8, 2021, and the remainder shall vest in equal monthly installments thereafter until fully vested on December 8, 2024. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation.
Documents
Issuer
PDS Biotechnology Corp
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001769757
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:17 PM ET
- Size
- 5.6 KB